Hester Biosciences' joint venture (JV) company -- Hester Biosciences Nepal has successfully developed and launched its Live Thermo-tolerant PPR (Peste Des Petits) Vaccine - Nigerian 75/1 Strain, under the brand name Live Thermovac PPR Vaccine.
Hester Nepal recently got the regulatory approval and marketing authorisation from Department of Drug Administration (DDA), Nepal, for its commercial production and marketing. The vaccine has also been tested for thermo-stability and has received a quality certification from The Pan African Veterinary Centre of the African Union (AU-PANVAC).
Hester is now geared up for commercial production and marketing of its thermo-tolerant PPR vaccine from December 2020. The vaccine will be available in packs of 25, 50 and 100 doses.
Hester Biosciences Nepal is a joint venture company between Hester Biosciences and HIM Electronics set up to compliment the other range of vaccines already being produced by Hester Biosciences in India. Hester Biosciences is engaged in the manufacturing of poultry vaccines.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: